Heavy drinking and alcohol use disorder are major public health problems. Practitioners not
specialising in alcohol treatment are often unaware of the guidelines for preventing …

Importance The overdose epidemic continues in the US, with 107 941 overdose deaths in
2022 and countless lives affected by the addiction crisis. Although widespread efforts to train …

Importance The US Food and Drug Administration recognizes total abstinence and no heavy
drinking days as outcomes for pivotal pharmacotherapy trials for alcohol use disorder (AUD) …

Drug interactions are one of the most common causes of side effects in polypharmacy.
Alcoholics are a category of patients at high risk of pharmacological interactions, due to the …

Background Alcohol use disorder is a highly prevalent disease with multiple medications
available for treatment. The overall prevalence of patients receiving pharmacotherapy is …

Objective Update the evidence on use of pharmacotherapy for alcohol use disorder in a
Canadian population. Methods Using whole-population administrative data from Manitoba …

Objectives Several medications have been shown to be safe and effective for treating
alcohol use disorder (AUD); however, these medications are prescribed infrequently. We …

Aims To determine the pattern and extent of prescribing of medications for alcohol relapse
prevention (ARP) in England. Design Cross‐sectional. Setting Specialist drug and alcohol …

Introduction Despite the heavy toll of alcohol use disorder (AUD) in the US, efficacious
medications for AUD (MAUD) are rarely used. Minimal research has explored clinician …

Abstract Background The US Food and Drug Administration identifies abstinence and the
absence of heavy drinking days as outcomes for pharmacotherapy trials for alcohol use …